Terray Therapeutics is a company revolutionizing small molecule drug discovery through a platform that integrates wet lab science with artificial intelligence. By focusing on high-quality, large-scale data, Terray unlocks generative AI for solving complex therapeutic challenges. The company's platform accelerates the drug discovery process with an experimental dataset containing billions of target-ligand binding measurements, supported by deep learning regression models. Terray Therapeutics prioritizes immunology internally but also collaborates with pharmaceutical and biotech organizations to tackle a variety of tough targets and therapeutic areas.